Chugai Pharmaceutical Co., Ltd. completed the full acquisition of Renalis Pharma Co., Ltd. on November 27, 2025, and finalized the absorption-type merger with Chugai Pharmaceutical Co., Ltd. as the surviving company and Renalis Pharma Co., Ltd. as the absorbed company on December 30, 2025.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4519","jir_company_name":"Chugai Pharmaceutical Co., Ltd.","jir_importance":"\u26053","jir_publication_date":"2025-12-30","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2025\/12\/4519-20251230-01.pdf","jir_short_summary":"Chugai Pharmaceutical Co., Ltd. completed the full acquisition of Renalis Pharma Co., Ltd. on November 27, 2025, and finalized the absorption-type merger with Chugai Pharmaceutical Co., Ltd. as the surviving company and Renalis Pharma Co., Ltd. as the absorbed company on December 30, 2025.","jir_summary":"### Overview of Organizational Restructuring\nChugai Pharmaceutical Co., Ltd. acquired full ownership of Renalis Pharma Co., Ltd. on November 27, 2025, and subsequently completed an absorption-type merger on December 30, 2025, with Chugai Pharmaceutical Co., Ltd. as the surviving company and Renalis Pharma Co., Ltd. as the absorbed and dissolved company. Legally, this merger followed the full acquisition, with the effective date being December 30, 2025. Details were disclosed in the notice 'Notice Regarding Absorption-type Merger of Full Subsidiary (Renalis Pharma Co., Ltd.)' dated November 18, 2025.\n\n### Purpose and Background of the Restructuring\nThis organizational restructuring aims to enhance group management efficiency and promote business integration through the full acquisition and absorption-type merger of Renalis Pharma Co., Ltd. This enables unified business operations, optimal allocation of management resources, and acceleration of decision-making.\n\n### Impact on Shareholders and Investors\nThere is no description regarding changes in capital structure or dividend policy resulting from the absorption-type merger. The specific impact on consolidated financial results has not been disclosed and remains unknown. For investors, the strengthening of group business integration may potentially enhance corporate value in the future; however, no direct impact is indicated at this time.","jir_financial_highlights":"Revenue of Affected Business: Unknown (Unknown)\nImpact on Consolidated Financial Results: Unknown (Unknown)","jir_category":"Corporate Restructuring, Strategy\/Investment","jir_hashtags":"#ChugaiPharmaceutical, #OrganizationalRestructuring, #JapaneseStocks","jir_key_figures":"Type of Split: Absorption-type Merger\nRevenue of Affected Business: Unknown\nEffective Date: 2025-12-30\nSuccessor Company: Chugai Pharmaceutical Co., Ltd. (Surviving Company in Absorption-type Merger)\nImpact on Consolidated Financial Results: Unknown","jir_meta_title":"Notice of Completion of Full Acquisition and Absorption-type Merger of Renalis Pharma Co., Ltd. by Chugai Pharmaceutical Co., Ltd.","jir_meta_description":"Chugai Pharmaceutical Co., Ltd. fully acquired Renalis Pharma Co., Ltd. on November 27, 2025, and completed an absorption-type merger on December 30, 2025. This notice provides details on the organizational restructuring and its impact on shareholders.","jir_og_title":"Chugai Pharmaceutical Co., Ltd. Completes Full Acquisition and Absorption-type Merger of Renalis Pharma Co., Ltd.","jir_og_description":"Chugai Pharmaceutical Co., Ltd. completed the full acquisition and absorption-type merger of Renalis Pharma Co., Ltd. This summary explains the overview of the restructuring and its impact on investors.","jir_og_image_url":"\/assets\/og\/company-corporate-restructuring.jpg","jir_chart_data_collection":"[]","ir_related_company":6836,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"corporate_restructuring","footnotes":""},"sector":[],"importance":[],"class_list":["post-9717","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n